Many of us wash our faces with hot water to open and clear our pores, finishing with cold water to close them. Not to mention ...
FDA Breakthrough Therapy designation received for PF614-MPAR ~~ PF614-MPAR second clinical trial initiated ~~ Lead clinical candidate identified for OUD program ~~ PF614 Phase 3 trial poised to commen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback